2015 ASH Annual Meeting - Complete Meeting
Description
As the premier event in malignant and non-malignant hematology, the ASH annual meeting provides attendees with an outstanding educational experience that examines the latest clinical advances in hematology and explores the year's most significant scientific discoveries and updates. The videos make this event available for convenient, on-demand viewing.
ASH now offers three package options, where you can choose between scientific and educational content, or purchase both at a lower price.
The 2015 ASH Annual Meeting webcast (full package) includes all of the following sessions:
- General Sessions
- Special-Interest Sessions
- Trainee Simultaneous Didactic Sessions
- Education Program Sessions
- Education Spotlight Sessions
- Scientific Program Sessions [NEW]
- Special Scientific Symposia [NEW]
- Scientific Spotlight Sessions [NEW]
Pricing
| Member Type | Price |
|---|---|
| List Price | $600.00 |
| Active, International, Emeritus, and Honorary Members | $350.00 |
| Associate, International Associate, Student, and Resident Members | $150.00 |
Sessions
Education Program
- Anemia: When Something's Wrong with Iron
- Challenges in Hemophilia Care
- Challenging Scenarios in Thrombosis
- Contemporary Therapy of Lymphoma
- Cytosis: Too Much of a Good Thing
- Evolving Issues in Anticoagulation
- Great Expectations: Hematology in Pregnancy
- Guiding Hematologic Care with Genetic Testing
- Hemophagocytic Lymphohistiocytosis in Adults
- Imaging and Treating the Clot: What's New?
- Immunological Ctrl-Alt-Del: Stem Cell Transplantation For Hematological Malignancies
- Junior-Faculty Development Education Session: Understanding the Basics of the Academic Job
- Management of Challenging Bleeding Complications
- Managing Typical and Atypical Chronic Myeloid Leukemia
- Multiple Advances In Myeloma
- Myelodysplastic Syndromes: Evolving Diagnosis and Therapy
- Myeloproliferative Neoplasms: A Clinical Update
- New Approaches in Chronic Lymphocytic Leukemia and Prolymphocytic Leukemia
- New Insights in Hemolytic Anemia
- Novel Approaches to Acute Lymphoblastic Leukemia
- Optimizing Therapy in Sickle Cell Disease
- Optimizing Transfusion Therapy (AABB Session)
- Palliative Care in Hematological Malignancies
- Patient-Reported Outcomes in Hematology
- Pediatric Hematological Malignancies: Beyond Acute Lymphocytic Leukemia
- Practical Management of T-Cell and Natural Killer Cell Lymphomas
- Recent Advances in Histiocytic Neoplasms
- Treatment of Acute Myeloid Leukemia: Moving Beyond 3 + 7
- Update in Large Cell Lymphoma
- Update on Diagnosis and Management of Thrombotic Thrombocytopenic Purpura
General Sessions
- Announcement of Awards: Mentor Award, Outstanding Service Award, Public Service Award, Wallace H. Coulter Award for Lifetime Achievement in Hematology
- Announcement of Awards: William Dameshek Prize, Henry M. Stratton Medal
- ASH/EHA Joint Symposium
- Best of ASH
- E. Donnall Thomas Lecture and Prize
- Ernest Beutler Lecture and Prize
- Ham-Wasserman Lecture: Game of Clones: Genomic Evolution of Severe Congenital Neutropenia
- Presidential Symposium
Scientific Program
- Advances in the Understanding and Diagnosis of Myelodysplasia and Bone Marrow Failure Syndromes
- Aging and Thrombosis
- Checkpoint, Please?
- Clonal Architecture and Hierarchy: Implications for Biology and Translation
- Determinants of Clot Structure: Beyond Fibrin
- Genetics vs. Response: What Should Direct Future Therapy of Childhood Acute Lymphoblastic Leukemia?
- Genome Therapies for Hemoglobinopathies
- Genomics, The Next Frontier: Novel Approaches to Study Cancer and Development
- Harnessing T Cells in Therapy of Hematologic Malignancy
- Hematopoiesis and the Niche
- Inflammatory Signaling: Tailoring Myelopoiesis in Health and Disease
- Mechanism of Phosphatidylserine Exposure
- Recent Insights into Efficacy of Red Blood Cells in Transfusions and Physiology
- Send in the Clones: Stem Cell Succession, Replicative Stress and Somatic Reversion
- Take a Breath: Heme, Iron, and Cellular Metabolism
- Targeting the Tumor Microenvironment in Lymphoid Malignancies
- Telomeres and Bone Marrow Failure
- The Path Toward Curing Multiple Myeloma
Special Scientific Symposia
Special-Interest Sessions
- ASH/ASCP Summit on Myelodysplastic Syndromes
- ASH/FDA Joint Symposium on Late-Breaking Drug Approvals
- How to Get Published in a Peer-Reviewed Journal
- Social Media for the Hematologist
- Special Education Session on Newly Approved Drugs
- Special Symposium on Quality
- The ASH Choosing Wisely® Campaign: Top 5 Non-ASH Choosing Wisely® Recommendations of Relevance to Hematology
- The Epic Story of Blood
Spotlight Sessions
- Addressing Severe Thrombocytopenia in the Care of Patients with Myelodysplastic Syndromes and Other Hematological Malignancies
- Beyond Transcription: Translational Control of Gene Expression in Development and Disease
- Challenging Anticoagulation Scenarios
- Infections and the Blood Supply
- Optimal Delivery of the Neonate with a Bleeding Disorder
- Overcoming Obstacles to Activating and Accruing in Clinical Trials on Hematological Malignancies
- Plasma Cell Disorders Other Than Myeloma
- Returning Diagnostic, Uncertain and Incidental Genomic Results
Trainee Activities and Services
- Trainee Simultaneous Didactic Session: Application of Microarray, Next Generation Sequencing, and Large Datasets to Hematology and Bioinformatics
- Trainee Simultaneous Didactic Session: Career Choice: Academic vs. Practice vs. Industry
- Trainee Simultaneous Didactic Session: How to Give Feedback to Students and Employees
- Trainee Simultaneous Didactic Session: How to Set Up a Laboratory Based Research Program
ASH Meeting on Hematologic Malignancies
Hear the latest developments in clinical care, and get answers to your most challenging patient care questions.
Learn more
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
Copyright © 2021 by American Society of Hematology